These emerging medications , Semaglutide , represent a groundbreaking advancement in treating type 2 diabetes and conceivably related conditions . They are classified as GLP-1 hormone activators , https://larissaywiy518832.goabroadblog.com/40145272/retatrutide-a-deep-dive-into-glp-1-compounds